235 related articles for article (PubMed ID: 18410580)
1. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
[TBL] [Abstract][Full Text] [Related]
2. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthase expression and clinicopathological findings in endometrial cancer.
Tsuji T; Yoshinaga M; Togami S; Douchi T; Nagata Y
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):586-90. PubMed ID: 15144342
[TBL] [Abstract][Full Text] [Related]
5. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
6. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
[TBL] [Abstract][Full Text] [Related]
7. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
[TBL] [Abstract][Full Text] [Related]
8. FAS and ErbB2 expression in early local recurrent oral cancer.
Pinto LS; de Aguiar FC; Kowalski LP; Graner E; Lopes MA
J Oral Pathol Med; 2010 Feb; 39(2):176-81. PubMed ID: 19691458
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance.
Zhao D; Pan J; Li XQ; Wang XY; Tang C; Xuan M
J Oral Pathol Med; 2008 Nov; 37(10):616-25. PubMed ID: 19012622
[TBL] [Abstract][Full Text] [Related]
10. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth.
Pimenta Amaral TM; Da Silva Freire AR; Carvalho AL; Pinto CA; Kowalski LP
Oral Oncol; 2004 Sep; 40(8):780-6. PubMed ID: 15288831
[TBL] [Abstract][Full Text] [Related]
12. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
[TBL] [Abstract][Full Text] [Related]
13. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tomoyose T; Tanaka T; Fukuyama H; Takahashi T
J Oral Pathol Med; 2005 Jul; 34(6):329-33. PubMed ID: 15946179
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lu CF; Huang CS; Tjiu JW; Chiang CP
Head Neck; 2010 Jan; 32(1):18-25. PubMed ID: 19484765
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and proliferation markers in tongue squamous cell carcinomas.
Gueiros LA; Coletta RD; Kowalski LP; Lopes MA
Int J Oral Maxillofac Surg; 2011 May; 40(5):510-5. PubMed ID: 21277167
[TBL] [Abstract][Full Text] [Related]
17. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
[TBL] [Abstract][Full Text] [Related]
18. [Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue].
Chen WL; Zeng SG; Li HG; Huang HZ; Pan CB
Ai Zheng; 2002 Mar; 21(3):314-8. PubMed ID: 12452003
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
